Liraglutide Cost in Missouri (2026): Cash Price, Insurance, and Compounded Options

What Liraglutide Actually Costs in Missouri Right Now

The sticker price for liraglutide varies widely depending on where and how you fill the prescription. Novo Nordisk lists the branded product (Saxenda for weight management, Victoza for type 2 diabetes) at $1,349 per month. Missouri retail pharmacies charge an average cash-pay price of about $900 per month in 2026, though individual pharmacy pricing can swing by several hundred dollars within the same metro area.

Branded vs. Generic vs. Compounded Pricing

Liraglutide lost patent exclusivity for certain indications, and generic versions from manufacturers like Teva have entered the market. Generic pricing at Missouri retail pharmacies typically falls between $600 and $850 per month without insurance. The SCALE Obesity and Prediabetes trial (N=3,731) demonstrated that liraglutide 3.0 mg produced 8.0% mean body weight loss versus 2.6% with placebo at 56 weeks [1], making even the higher price points clinically justifiable for many patients. Compounded liraglutide from 503A pharmacies represents the lowest-cost option at roughly $150 per month [2].

Why Missouri Prices Differ From National Averages

Missouri has no state-level drug pricing transparency law comparable to those in Colorado or Oregon. Pharmacy benefit managers (PBMs) negotiate rates independently with each payer, and the resulting price spread can be significant. A patient filling at a large chain in St. Louis might pay $875, while a rural pharmacy in the Ozarks could charge $950 for the same product.

Missouri Medicaid Coverage for Liraglutide

Missouri Medicaid (MO HealthNet) covers liraglutide for type 2 diabetes management. It does not cover liraglutide when prescribed solely for chronic weight management. This distinction matters because the FDA approved liraglutide under two separate brand names and indications: Victoza (type 2 diabetes, up to 1.8 mg daily) and Saxenda (weight management, 3.0 mg daily) [3].

Prior Authorization Requirements

MO HealthNet requires prior authorization for liraglutide. Prescribers must document a diagnosis of type 2 diabetes with inadequate glycemic control on at least one first-line oral agent (typically metformin). The PA form asks for a recent HbA1c value, BMI, and a list of failed or contraindicated therapies. Approval periods typically run 6 to 12 months before renewal is required.

The Weight Management Gap

Patients who need liraglutide specifically for obesity (without a concurrent type 2 diabetes diagnosis) face out-of-pocket costs under Missouri Medicaid. The American Association of Clinical Endocrinology (AACE) 2023 obesity guidelines recommend GLP-1 receptor agonists as first-line pharmacotherapy for patients with BMI ≥30 or BMI ≥27 with weight-related comorbidities [4]. Despite this guideline support, Missouri Medicaid has not expanded coverage to match.

Private Insurance Coverage in Missouri

Commercial insurance plans in Missouri handle liraglutide coverage unevenly. The three largest insurers in the state (Anthem Blue Cross Blue Shield, UnitedHealthcare, and Cigna) each apply different formulary tiers and prior authorization criteria.

Employer-Sponsored Plans

Most large employer-sponsored plans in Missouri place generic liraglutide on a preferred brand or specialty tier, resulting in copays between $50 and $150 per month after deductible. Plans that exclude anti-obesity medications (AOMs) will deny coverage for the Saxenda indication but may approve Victoza for diabetes. A 2023 Kaiser Family Foundation survey found that only 45% of large employer plans covered at least one AOM [5].

Marketplace (ACA) Plans

Missouri ACA marketplace plans sold through healthcare.gov vary by metal tier and carrier. Silver and Gold plans from Anthem and Centene frequently include liraglutide for diabetes on their formularies. Weight management coverage remains rare on marketplace plans. Patients should check the specific formulary for their plan year, as Missouri insurers update drug lists annually in October.

Medicare Part D

Medicare Part D covers liraglutide for type 2 diabetes (Victoza). The Inflation Reduction Act capped Medicare Part D out-of-pocket costs at $2,000 per year starting in 2025 [6], which benefits patients on high-cost injectables. Medicare does not cover liraglutide for weight loss under current statute.

Compounded Liraglutide in Missouri: Legality, Cost, and Risks

Compounded liraglutide is legal in Missouri when dispensed by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. The Missouri Board of Pharmacy regulates 503A compounding facilities, and federal oversight falls under FDA section 503A of the Federal Food, Drug, and Cosmetic Act [7].

How 503A Compounding Works

A 503A pharmacy compounds liraglutide in response to an individual prescription from a licensed prescriber. The pharmacy sources pharmaceutical-grade liraglutide peptide, reconstitutes it to the prescribed concentration, and dispenses it directly to the patient. Pricing near $150 per month reflects the lower overhead of compounding versus branded manufacturing, packaging, and marketing.

Quality and Safety Considerations

Compounded medications do not undergo FDA premarket review. The FDA has issued warnings about certain compounded GLP-1 products containing salt forms (such as liraglutide acetate) that differ from the FDA-approved formulation [8]. Patients should verify that their 503A pharmacy holds current Missouri Board of Pharmacy licensure and, ideally, PCAB (Pharmacy Compounding Accreditation Board) accreditation. Asking the pharmacy for a certificate of analysis (COA) on each batch provides an additional layer of quality assurance.

When Compounded Liraglutide May Not Be Available

If the FDA determines that liraglutide is no longer in shortage, 503B outsourcing facilities may be required to stop producing it. 503A pharmacies operate under different rules and can typically continue compounding regardless of shortage status, provided the prescription is patient-specific. Missouri patients should stay informed about FDA shortage list updates.

Savings Strategies That Work in Missouri

Several approaches can reduce liraglutide costs below the standard retail price. Not every strategy applies to every patient, and combining methods is sometimes possible.

Manufacturer Savings Cards

Novo Nordisk offers savings cards for both Saxenda and Victoza that can reduce out-of-pocket costs to as low as $25 per month for commercially insured patients. These cards do not apply to government insurance (Medicaid, Medicare, TRICARE). Eligibility requires commercial insurance coverage of the drug; the card covers the difference between the copay and $25. Patients can enroll through the Saxenda or Victoza brand websites.

GoodRx and Discount Platforms

Cash-pay discount platforms like GoodRx aggregate pricing across Missouri pharmacies and can reduce costs below the average $900 mark. Discounts vary by pharmacy and by week, so checking multiple platforms before each fill is worth the effort. These coupons cannot be combined with insurance.

Patient Assistance Programs

Novo Nordisk's Patient Assistance Program (PAP) provides free medication to uninsured or underinsured patients who meet income thresholds (typically at or below 400% of the federal poverty level). The application requires proof of income and a letter from the prescriber. Processing takes 4 to 6 weeks, and approval covers a 90-day supply with renewal options [9].

Switching to Compounded

For patients paying full cash price, switching to compounded liraglutide from a licensed Missouri 503A pharmacy reduces monthly cost from approximately $900 to $150. The prescriber writes the prescription specifying compounded liraglutide, and the patient fills it at a pharmacy that compounds GLP-1 receptor agonists. Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women's Hospital, has noted: "Access to effective obesity pharmacotherapy should not be limited by cost barriers that compounding can reasonably address, provided quality standards are maintained."

Telehealth Prescribing of Liraglutide in Missouri

Missouri permits telehealth prescribing of liraglutide with no in-person visit requirement for the initial consultation. The Missouri Telemedicine Act, updated in 2021, allows prescribers to establish a patient-provider relationship via synchronous audio-video communication [10].

What a Telehealth Visit Looks Like

A typical telehealth consultation for liraglutide includes a medical history review, BMI calculation based on self-reported or verified height and weight, discussion of prior weight loss attempts, and screening for contraindications (personal or family history of medullary thyroid carcinoma or MEN 2 syndrome). The prescriber may order baseline labs (HbA1c, lipid panel, renal function) through a local Missouri lab.

Telehealth Platforms Serving Missouri

Several national telehealth platforms prescribe liraglutide to Missouri residents, including HealthRX. Consultation fees range from $50 to $200 for the initial visit. Some platforms bundle the consultation fee with the medication cost when using a partner compounding pharmacy. Prescriptions can be sent to any Missouri pharmacy, whether retail or 503A compounding.

Liraglutide Dosing and What It Means for Monthly Cost

Liraglutide dosing follows a titration schedule that affects the amount of drug consumed per month. The FDA-approved titration for weight management starts at 0.6 mg daily for one week, then increases by 0.6 mg weekly until reaching the maintenance dose of 3.0 mg daily [3].

Cost During Titration

During the first four weeks of titration (0.6 mg to 2.4 mg), patients use less drug per day than at maintenance. A single Saxenda pen contains 18 mg of liraglutide. At the 3.0 mg maintenance dose, one pen lasts 6 days, and patients need approximately 5 pens per month. During early titration, the same pen lasts longer, meaning the first month's supply costs less. Patients paying cash should ask about purchasing fewer pens during the titration period.

Diabetes vs. Weight Management Dosing

The maximum approved dose for type 2 diabetes (Victoza) is 1.8 mg daily, which uses 40% less drug per day than the 3.0 mg weight management dose. This lower dose translates directly to lower monthly cost. Patients prescribed 1.8 mg need roughly 3 pens per month instead of 5, reducing the cash price proportionally.

Clinical Evidence Supporting Liraglutide Use

The efficacy data behind liraglutide comes from large, well-designed randomized controlled trials.

SCALE Obesity and Prediabetes

The SCALE trial enrolled 3,731 adults with BMI ≥30 (or ≥27 with comorbidities) and randomized them to liraglutide 3.0 mg or placebo for 56 weeks. The liraglutide group lost a mean of 8.0% of body weight versus 2.6% in the placebo group. 63.2% of the liraglutide group achieved ≥5% weight loss compared with 27.1% on placebo [1]. The trial also showed a 79% reduction in type 2 diabetes incidence over 3 years of follow-up among participants with prediabetes at baseline.

LEADER Cardiovascular Outcomes Trial

The LEADER trial (N=9,340) evaluated liraglutide 1.8 mg in patients with type 2 diabetes and high cardiovascular risk. Over a median follow-up of 3.8 years, liraglutide reduced the composite primary endpoint (cardiovascular death, nonfatal MI, nonfatal stroke) by 13% compared with placebo (HR 0.87, 95% CI 0.78 to 0.97, P=0.01) [11]. This cardiovascular benefit influenced the ADA Standards of Care to recommend GLP-1 receptor agonists for patients with type 2 diabetes and established atherosclerotic cardiovascular disease [12].

Safety Profile

Common side effects include nausea (reported in 39% of patients in SCALE), diarrhea, constipation, and injection-site reactions. Nausea typically peaks during dose titration and diminishes over 4 to 8 weeks. Liraglutide carries a boxed warning regarding thyroid C-cell tumors based on rodent studies, though no causal link has been established in humans [3]. The drug is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

Missouri-Specific Resources for Patients

Missouri residents have several state-level resources that can help with medication access.

The Missouri Department of Social Services administers MO HealthNet and publishes its preferred drug list (PDL) online, where patients can verify liraglutide coverage status. The Missouri Board of Pharmacy maintains a searchable database of licensed pharmacies, including those with compounding permits. Patients can verify a pharmacy's 503A status before filling a compounded liraglutide prescription.

The Endocrine Society's 2024 guidelines recommend that clinicians consider cost when selecting obesity pharmacotherapy and suggest exploring all available access pathways, including patient assistance programs and compounding, before discontinuing treatment due to affordability [13]. Missouri patients who lose insurance coverage or face a formulary change mid-year should contact their prescriber promptly to discuss alternatives rather than stopping liraglutide abruptly, as weight regain after discontinuation is well documented.

Patients filling compounded liraglutide in Missouri should store the reconstituted injection at 36°F to 46°F (2°C to 8°C) and use each vial within the timeframe specified by the compounding pharmacy, typically 28 to 42 days after first use.